TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 101 filers reported holding TANGO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,571,385 | +410.5% | 2,892,663 | +50.5% | 3.64% | +454.3% |
| Q2 2023 | $6,380,343 | +83951.4% | 1,921,790 | 0.0% | 0.66% | -30.8% |
| Q1 2023 | $7,591 | -45.5% | 1,921,790 | 0.0% | 0.95% | -39.0% |
| Q4 2022 | $13,933 | -99.8% | 1,921,790 | 0.0% | 1.56% | +87.6% |
| Q3 2022 | $6,957,000 | -20.1% | 1,921,790 | 0.0% | 0.83% | -18.7% |
| Q2 2022 | $8,706,000 | -40.2% | 1,921,790 | 0.0% | 1.02% | -27.8% |
| Q1 2022 | $14,567,000 | -30.7% | 1,921,790 | 0.0% | 1.42% | -15.1% |
| Q4 2021 | $21,024,000 | -15.4% | 1,921,790 | 0.0% | 1.67% | +8.2% |
| Q3 2021 | $24,849,000 | – | 1,921,790 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |